Related references
Note: Only part of the references are listed.In Vitro Biopredictive Methods: A Workshop Summary Report
Xavier J. H. Pepin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Advances in In Vivo Predictive Dissolution Testing of Solid Oral Formulations: How Closer to In Vivo Performance?
Meera Shrivas et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2020)
In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing
Moawia M. Al-Tabakha et al.
PHARMACEUTICS (2020)
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
Marival Bermejo et al.
PHARMACEUTICS (2020)
Tablets of Hydrochlorothiazide in Cyclodextrin in Nanoclay: A New Nanohybrid System with Enhanced Dissolution Properties
Francesca Maestrelli et al.
PHARMACEUTICS (2020)
Biphasic Dissolution as an Exploratory Method during Early Drug Product Development
Daniela Amaral Silva et al.
PHARMACEUTICS (2020)
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
Marival Bermejo et al.
PHARMACEUTICS (2020)
Delay differential equations for the description of Irbesartan pharmacokinetics: A population approach to model absorption complexities leading to dual peaks
Eleni Karatza et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach
Bárbara Sánchez-Dengra et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration
James Butler et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization
Laszlo Endrenyi et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation
Marcelo Dutra Duque et al.
PHARMACEUTICS (2019)
In silico Tools at Early Stage of Pharmaceutical Development: Data Needs and Software Capabilities
Juliet Obianuju Njoku et al.
AAPS PHARMSCITECH (2019)
Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug
Ziqiang Li et al.
AAPS PHARMSCITECH (2019)
Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation
I. Gonzalez-Garcia et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project
Bart Hens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Establishing in vitro-in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach
Dhaval K. Shah et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
In Vitro Dissolution as a Tool for Formulation Selection: Telmisartan Two-Step IVIVC
Alejandro Ruiz Picazo et al.
MOLECULAR PHARMACEUTICS (2018)
Power of the Dissolution Test in Distinguishing a Change in Dosage Form Critical Quality Attributes
Vivian A. Gray
AAPS PHARMSCITECH (2018)
A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives
M. A. Nguyen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context
H. Lennernas et al.
MOLECULAR PHARMACEUTICS (2017)
Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers
Sharvari Bhagwat et al.
PHARMACEUTICAL RESEARCH (2017)
Production of Irbesartan Nanocrystals by High Shear Homogenisation and Ultra-Probe Sonication for Improved Dissolution Rate
Karthik Sridhar et al.
CURRENT DRUG DELIVERY (2016)
Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid
Ana Cuesta-Gragera et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions
Palash Sanphui et al.
MOLECULAR PHARMACEUTICS (2015)
Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems
Nicholas A. Peppas et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Current Challenges in Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products
Avraham Yacobi et al.
PHARMACEUTICAL RESEARCH (2014)
A Pharmacokinetic Simulation Tool for Inhaled Corticosteroids
Benjamin Weber et al.
AAPS JOURNAL (2013)
Population-based meta-analysis of hydrochlorothiazide pharmacokinetics
Scott A. Van Wart et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
The role of the upper sample size limit in two-stage bioequivalence designs
Vangelis Karalis
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Mathematical modeling of drug dissolution
J. Siepmann et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Determination of Bioequivalence for Drugs with Narrow Therapeutic Index: Reduction of the Regulatory Burden
Laszlo Endrenyi et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2013)
In Vitro Bioequivalence Approach for a Locally Acting Gastrointestinal Drug: Lanthanum Carbonate
Yongsheng Yang et al.
MOLECULAR PHARMACEUTICS (2013)
A Technique to Estimate In Vivo Dissolution Profiles Without Data from a Solution
Jack A. Cook
AAPS JOURNAL (2012)
On the leveling-off properties of the new bioequivalence limits for highly variable drugs of the EMA guideline
Vangelis Karalis et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Variability and Impact on Design of Bioequivalence Studies
Achiel Van Peer
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Examining the Role of Metabolites in Bioequivalence Assessment
Vangelis Karalis et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
In Vitro Dissolution Testing with Flow-Through Method: A Technical Note
Zongming Gao
AAPS PHARMSCITECH (2009)
Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Linear kinetics (I)
Carlos Fernandez-Teruel et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics
Carlos Fernandez-Teruel et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Regulatory Conditions for the Determination of Bioequivalence of Highly Variable Drugs
Laszlo Endrenyi et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2009)
Mathematical modeling of drug delivery
J. Siepmann et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Bioavailability and Bioequivalence: Focus on physiological factors and variability
Vangelis Karalis et al.
PHARMACEUTICAL RESEARCH (2008)
Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests:: influence of age, sex and body mass index
Stephan Hellmig et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Population pharmacokinetics of amlodipine in hypertensive children and adolescents
Joseph T. Flynn et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Modeling and comparison of dissolution profiles
P Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
